Notice of Intent to Sole Source - CBTRUS - Malignant and Non-Malignant Tumors

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to the Central Brain Tumor Registry of the United States (CBTRUS) for Enhanced Evaluation, Training, and Analysis of Brain and Central Nervous System Malignant and non-Malignant Tumors. The Central Brain Tumor Registry of the United States (CBTRUS) is the only population-based brain and CNS-specific cancer registry in the United States. Its database is comprised of the largest histology-specific aggregation of population-based data limited to the incidence of primary brain and CNS tumors in the United States, enabling evaluation and analysis of population-based incidence rates for all primary brain and CNS tumors by histopathology, behavior, site, age, sex, race, ethnicity, and geography. No other site-specific population-based primary brain and central nervous system tumor registry exists in the United States; and no other organization represents the level of brain and CNS tumor subject matter experts available through the CBTRUS. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at qna4@cdc.gov by COB 01 July 2023